Cart
sales@molnova.com
BIBR 1087 SE
CAS No. 212321-78-3
BIBR 1087 SE ( Desethyl Dabigatran Etexilate )
Catalog No. M23967 CAS No. 212321-78-3
BIBR 1087 SE is a metabolite of dabigatran etexilate.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 83 | In Stock |
|
| 5MG | 135 | In Stock |
|
| 10MG | 237 | In Stock |
|
| 25MG | 500 | In Stock |
|
| 50MG | 718 | In Stock |
|
| 100MG | 981 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBIBR 1087 SE
-
NoteResearch use only, not for human use.
-
Brief DescriptionBIBR 1087 SE is a metabolite of dabigatran etexilate.
-
DescriptionBIBR 1087 SE is a metabolite of dabigatran etexilate.
-
SynonymsDesethyl Dabigatran Etexilate
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number212321-78-3
-
Formula Weight599.7
-
Molecular FormulaC32H37N7O5
-
Purity>98% (HPLC)
-
SolubilityDMSO:100 mg/mL (166.76 mM)
-
SMILESO=C(N(C1=CC=CC=N1)CCC(O)=O)C2=CC=C(N(C)C(CNC3=CC=C(C(NC(OCCCCCC)=O)=N)C=C3)=N4)C4=C2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Stangier J, et al. Pharmacokinetics and pharmacodynamics of dabigatran etexilate, an oral direct thrombin inhibitor, are not affected by moderate hepatic impairment. J Clin Pharmacol. 2008 Dec;48(12):1411-9.
molnova catalog
related products
-
Biotin-PEG4-azide
Biotin-PEG4-azide is a biotin-labeled, PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
-
cAC 253
Amylin (AMY3) antagonist (IC50 = 0.3 μM). Protects neuronal cells from Aβ(1-42)-induced cytotoxicity in vitro. Brain penetrant. Improves spatial memory and reduces Aβ plaque number and total area in a mouse Alzheimer's disease model.
-
Exherin
Exherin (ADH-1) is a small, cyclic pentapeptide vascular-targeting agent with potential antineoplastic and antiangiogenic activities.
